Akero Therapeutics, Inc. (AKRO) - Balance Sheet Statement

Home
AKRO
Financials

28.25 (USD) • At close December 27, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	234.207	249.773	150.483	187.242	136.4	75.975	0.598
Short Term Investments Numbers are in millions	315.803	101.676	37.775	81.145	71.612	0	0
Cash and Short Term Investments Numbers are in millions	550.01	351.449	188.258	268.387	136.4	75.975	0.598
Net Receivables Numbers are in millions	0	0	0	0	0	0	0
Inventory Numbers are in millions	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	9.952	7.448	10.648	5.916	3.298	2.312	0.08
Total Current Assets Numbers are in millions	559.962	355.173	193.582	271.345	138.049	77.131	0.638
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	1.026	1.289	1.549	1.793	0	0	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	19.283	0	0	0.04	0.04	0.02	0.02
Tax Assets Numbers are in millions	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0	0.108	0.417	0.161	0.029	0	0
Total Non-Current Assets Numbers are in millions	20.309	1.397	1.966	1.994	0.069	0.02	0.02
Total Assets Numbers are in millions	580.271	356.57	195.548	273.339	138.118	77.151	0.658
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	7.038	7.968	6.706	3.428	0.947	1.373	0.06
Short Term Debt Numbers are in millions	0.522	0.325	0.205	0.294	0.085	0	0
Tax Payables Numbers are in millions	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	0	0	0
Other Current Liabilities Numbers are in millions	11.568	10.79	18.217	9.389	8.337	0.969	0.162
Total Current Liabilities Numbers are in millions	19.128	19.083	25.128	13.111	9.369	2.342	0.222
Non-Current Liabilities:
Long Term Debt Numbers are in millions	25.783	10.62	2.622	3.032	0	0	0
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0.054	0.305	-1.311	-1.516	0.023	124.728	5
Total Non-Current Liabilities Numbers are in millions	25.837	10.925	1.311	1.516	0.023	124.728	5
Total Liabilities Numbers are in millions	44.965	30.008	26.439	14.627	9.392	127.07	5.222
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	138.118	124.728	5
Common Stock Numbers are in millions	0.006	0.005	0.004	0.004	0.003	0	0
Retained Earnings Numbers are in millions	-574.096	-422.337	-310.304	-209.527	-130.32	-86.565	-4.564
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0.27	0.037	-0.027	-0.003	-0.006	0	0
Other Total Stockholders Equity Numbers are in millions	1,109.126	748.857	479.436	468.238	259.049	-88.082	-5
Total Shareholders Equity Numbers are in millions	535.306	326.562	169.109	258.712	128.726	-49.919	-4.564
Total Equity Numbers are in millions	535.306	326.562	169.109	258.712	128.726	-49.919	-4.564
Total Liabilities & Shareholders Equity Numbers are in millions	580.271	356.57	195.548	273.339	138.118	77.151	0.658

Akero Therapeutics, Inc.

NASDAQ:AKRO Add to watchlist

NASDAQ:AKRO